Click to visit the ESCRS website
From September 12 to 16, 2025, OphtAI, an Artificial Intelligence solution dedicated to ophthalmologic screening, will be attending the ESCRS Congress in Copenhagen, Denmark. Visit us at booth E062 – Bella Center.
This major event offers a unique opportunity to explore cutting-edge technologies shaping the future of visual health, in line with our commitment to responsible innovation.
A constantly evolving AI solution
Developed in collaboration with renowned partners (AP-HP, UBO, Adcis), OphtAI is powered by advanced algorithms capable of automatically detecting a wide range of ocular pathologies, including:
- Naevi
- Hypertensive retinopathy
- Retinal vein occlusion (CRVO + BRVO)
- Macular hole
- Epiretinal membrane
- Cataract
- High myopia
- Retinitis pigmentosa
- Laser photocoagulation scars
- Pigment migration
- Retinal pigment epithelium alteration
- Normal / abnormal eye classification (patented technology)
- MIDD
These innovations complement the pathologies already detected by OphtAI, such as diabetic retinopathy*, AMD (age-related macular degeneration), and glaucoma.
* (detection and grading)
** (and Drusen detection for AMD)
MyOphtAI: Simplicity, Autonomy, Efficiency
In response to growing pressure on healthcare professionals, OphtAI is launching an innovative new service: MyOphtAI, a monthly subscription offer with no commitment, including a free trial and unlimited use.
👉 Zero hassle, zero click. Filing’s done, it’s automatic.
A strong network of partners and integrators
OphtAI is supported by a robust ecosystem of trusted integrators, including Topcon, Optomed, Crystalvue, and Umami View, and strategic partners such as Oplus, Téo, and Area. This collaborative approach ensures optimal interoperability and efficient field deployment.
Experience OphtAI live at our booth
At booth E062, you’ll have the opportunity to:
- Explore real-life use cases
- Speak with our AI experts
- Test our latest innovations in real-world conditions
A unique chance to discover how our technology enhances the work of eye care professionals, enabling early diagnosis, greater efficiency, and reduced disparities in access to eye care.